Northstrive Biosciences Completes Phase II of AI Development Program with YuvaBio, Utilizing MitoNova™ AI Platform to Create Therapies for Obesity and Cardiometabolic Conditions
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Source: Newsfilter
Collaboration Announcement: Northstrive Biosciences and Yuva Biosciences have completed Phase II of their AI Development Program, focusing on using YuvaBio's MitoNova™ platform to identify small molecule candidates aimed at improving mitochondrial health for treating obesity and cardiometabolic conditions.
Candidate Selection: YuvaBio has provided Northstrive with a shortlist of compounds derived from 12 curated libraries, which are intended for biological validation and potential advancement to experimental testing and clinical development.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ELAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ELAB
About ELAB
PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. Its segments include corporate, treasury and biosciences, IT packaging solutions and precision engineering and machining. The Company's portfolio consists of various subsidiaries: Northstrive BioSciences Inc., PMGC Research Inc., PMGC Capital LLC, Pacific Sun Packaging Inc. and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. AGA Precision Systems LLC specializes in CNC machining operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oversold Consumer Staples Stocks Present Investment Opportunities: ODD, ELAB, ZVIA
- Oversold Stock Overview: In the consumer staples sector, ODDITY Tech, PMGC Holdings, and Zevia have relative strength indices (RSI) below 30, at 25.3, 16.2, and 26 respectively, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- ODDITY Tech Rating Adjustment: Keybanc analyst maintained an Overweight rating on ODDITY Tech but lowered the price target from $70 to $50, reflecting market caution regarding its future performance, despite its stock price falling approximately 20% over the past month.
- PMGC Holdings Reverse Split: PMGC Holdings announced a 1-for-4 reverse split and invested in non-controlling shares of Nuclea Energy; however, its stock plummeted 73% over the past month, currently at a 52-week low of $3.54 with an RSI of 16.2.
- Zevia Stock Performance: Telsey Advisory Group analyst maintained an Outperform rating for Zevia with a price target of $6, even as its stock fell 33% over the past month to a 52-week low of $1.66, with an RSI of 26 indicating potential for a rebound.
Continue Reading
PMGC Holdings (ELAB) Shares Drop 16.46% After Nuclea Energy Investment Announcement
- Stock Volatility: PMGC Holdings (ELAB) shares fell 16.46% to $5.38, reflecting market concerns over its investment in Nuclea Energy, with the undisclosed investment amount indicating investor skepticism about the company's future growth potential.
- Investment Strategy: PMGC Capital's acquisition of non-controlling shares in Nuclea Energy, completed in November 2025, aims to support long-term growth in advanced energy infrastructure and decarbonization, although the negative market reaction may overshadow its strategic intentions.
- Market Reaction: On the announcement day, ELAB opened lower than the previous close, with significantly increased trading volume indicating heightened investor attention to the strategic transaction, which could impact the company's short-term market performance.
- Industry Outlook: Nuclea Energy focuses on developing micro modular nuclear reactors, and despite the current stock decline, the technology's potential for off-grid and industrial energy applications may yield long-term benefits for PMGC, reflecting the company's strategic positioning in the renewable energy sector.
Continue Reading